Concepedia

Patient-derived Xenografts Reveal that Intraductal Carcinoma of the Prostate Is a Prominent Pathology in BRCA2 Mutation Carriers with Prostate Cancer and Correlates with Poor Prognosis

Gail P. Risbridger, Renea A. Taylor, David Clouston, Ania Sliwinski, Heather Thorne, Sally M. Hunter, Jason Li, Gillian Mitchell, Declan G. Murphy, Mark Frydenberg,

European Urology · 2014 · 137 citations · 26 references

Concepts

MedicineOncologyUrologyCancer GeneticsGenitourinary OncologyMolecular OncologyCancer GenomicsCancer ProgressionHereditary Urologic Cancer SyndromesMalignant NeoplasmsProstate CancerProstate PathologyBrca MutationsBrca2 DeficiencyBrca2 FunctionBrca2 InactivationBrca2 Mutation RiskHereditary Prostate CancerProstate Cancer Histopathology

References

26

Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer

Anthony V. D’Amico · JAMA · 1998 · 4.5K citations

Medicine, Surgery, Urology +14

Identification of the breast cancer susceptibility gene BRCA2

Richard Wooster, Graham R. Bignell, Jonathan Lancaster et al. · Nature · 1995 · 3.7K citations

Medicine, Genetics, Molecular Genetics +9

The Risk of Cancer Associated with Specific Mutations of<i>BRCA1</i>and<i>BRCA2</i>among Ashkenazi Jews

Jeffery P. Struewing, Patricia Hartge, Sholom Wacholder et al. · New England Journal of Medicine · 1997 · 2.3K citations · Full text

Medicine, Genetics, Molecular Genetics +17

Cancer Risks in BRCA2 Mutation Carriers

JNCI Journal of the National Cancer Institute · 1999 · 1.5K citations · Full text

Medicine, Genetics, Oncology +17

TNM Classification of Malignant Tumours.

Annals of Internal Medicine · 1969 · 1.1K citations

Veterinary Medicine, Oncology, Pathology +14